Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations

Details for Australian Patent Application No. 2001270484 (hide)

Owner Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors Dammgen, Jurgen; Seidler, Randolph; Guth, Brian

Agent Davies Collison Cave

Pub. Number AU-B-2001270484

PCT Pub. Number WO01/78699

Priority 10018401 13.04.00 DE

Filing date 7 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 25 January 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/4168 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

13 May 2004 Change of Name(s) of Applicant(s), Section 104

  Boehringer Ingelheim Pharma KG The name of the applicant has been changed to Boehringer Ingelheim Pharma GmbH & Co. KG 2002

25 January 2007 Application Accepted

  Published as AU-B-2001270484

24 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001270485

2001270483